Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

BD Launches The New BD Nexiva Closed IV Catheter System In UK

BD Medical announced UK launch of the latest BD Nexiva Closed IV Catheter System designed to reduce healthcare workers' risk of needlestick injuries and minimise exposure to blood. The system includes the BD Q-Syte Luer Access Split Septum to aid reduce catheter-related bloodstream infections (CRBSIs).

The new version of the BD Nexiva system introduces key developments like new non-removable pinch clamp for easy, one-handed activation, soft stabilisation platform designed to decrease catheter movement and associated complications, whilst providing greater patient comfort and new catheter grip design which accommodates the various insertion techniques employed by clinicians and Larger bore extension tubing on 18G and 20G cannulas for improved flow rates.

Needlestick injuries are a significant risk to the physical and psychological health of nurses, this has been shown in many studies.

The all-in-one BD Nexiva system used for peripheral venous access is designed to reduce insertion attempts and limit healthcare workers’ exposure to blood with its innovative blood-containment system which helps minimise blood leakage from the catheter hub. The safety-engineered system is also designed to reduce needlestick injury by using passive needle-shielding technology.

A main feature incorporated into the BD Nexiva Closed IV Catheter System is the BD Q-Syte Luer Access Split Septum that offers an unobstructed and straight fluid path, high flow rates, cleanability and clear visibility. A split septum needle access system has 64-70% lower CRBSI rates when compared to mechanical valves. This split-septum device helps reduce the number of places where bacteria may thrive by eliminating the complexities of mechanical valves. Comparison studies found that patients are on average three times more likely to develop a CRBSI with mechanical valves versus a split-septum needle-less access system.